Dear Gov. Brown, What's a Vagina Worth? I Support Women's Rights

(800) 511-3838 |

Breast Implants Tied to Cancer

Breast Implants and Cancer – What They Knew, When They Knew It

One of the main protocols for surgery is that the doctor will explain the risks of anesthesia, how the procedure will be performed and ways to promote healing, but often overlooked is educating the patient of the potential adverse effects that can result from a defective medical implant. If you or a loved one have breast implants, you should be aware of the increased potential for developing breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.

What They Knew

A recent study published in the journal JAMA Oncology supports the belief that cancer has a definite link to breast implants. Anaplastic large cell lymphoma (ALCL), a type of non-Hodgkin lymphoma, has been found in approximately one in 7,000 women who have implants. Scientists believe that the implants or bacteria on the implants may trigger an inflammatory response that over time could be linked to cancer. Most of the cases of ALCL have been reported in women who had textured, not smooth implants.

So far, there have been 359 reports of implant-associated lymphoma from around the world and nine women have died. While these numbers may seem low, this report has just been published and most doctors and patients haven’t been made aware of the signs and symptoms of this potential disease. These numbers may also appear to be sparse because the average diagnosis appeared 13 years after the initial implant surgery which caused doctors to at first question if the implants caused the cancer. However, the JAMA study states that women with ALCL were about 421 times more likely to have breast implants.

When They Knew It

While this JAMA study may be new, the first cases of ALCL and breast implants were reported way back in 1997. The FDA also issued a report in 2011 which said that breast implants were associated with an increased risk of non-anaplastic large cell lymphoma and that, “the FDA is aware of approximately 60 case reports of ALCL in women with breast implants.”

If the FDA knew for several decades that there was a risk for women who had breast implants to develop cancer, why weren’t these women informed? They should have been made aware of the danger and should have been educated on what signs to look for to ensure early detection (such as pain, swelling, or redness).

What Can You Do?

If you or a loved one was diagnosed with breast cancer after having breast implant surgery, you may be eligible to make a claim. You should have been informed of the risk for breast cancer and the possible threat to your health. If you had breast cancer surgery, you most likely have expensive medical bills to pay for or you lost wages when you had to take time off of work to recover. You deserve financial compensation to since you weren’t made aware of the potential for future complications. Contact us today to determine if you can make a claim.

Breast Implant Warnings In The News

BREAKING (2/7/19): FDA reports additional cases of cancer linked to breast implants

 

A deadly cancer linked to breast implants has been found in additional women in the United States, federal health officials said.

At least 457 women in the United States have so far been diagnosed with anaplastic large cell lymphoma, the Food and Drug Administration said in a statement Wednesday. Of those, nine have died as a result of the rare cancer, which affects cells in the immune system and can be found around the breast implant.

Read Full Article

 

1/5/18: Breast Implants Linked to a Rare Cancer: How Big Is the Risk?

Women with breast implants are at increased risk of developing a rare type of cancer of the immune system, but the overall chance of getting this cancer from implants is very low, according to a new study from the Netherlands.

The study provides one of the most precise estimates to date of the risk for women with breast implants of developing this cancer, which is called anaplastic large cell lymphoma (ALCL), the researchers said. ALCL is not breast cancer; rather, it is a type of lymphoma, which is a cancer of the immune system cells. When it occurs in women with breast implants, the cancer typically appears in the scar tissue around the implant.

Read Full Article

1/4/18: Breast Implants Increase Cancer Risk, Large Lymphoma Study Shows

Breast implants are associated with an increased risk of a rare form of cancer, according to a new study published Thursday in JAMA Oncology. Although the issue has been known about for two decades, this is the largest study of the association between breast implants and lymphoma to date.

Scientists still sure how breast implants might be increasing a person’s risk of cancer. As the paper describes, the implant may trigger an inflammatory response. Alternatively, a bacterial species could be hitching a ride on the implant’s surface. Some women may even be genetically predisposed to develop this kind of cancer after a breast implant.

Read Full Article

1/4/18: Rates of Rare, Breast Implant-related Cancer May Be Higher Than Reported

A new study published Thursday confirms what oncologists have noticed for some time: that breast implants are associated with a small increased risk of cancer.

Health Canada insists the risk is very small, and that only five cases have been confirmed in the last 10 years. But CTV News has learned there have actually been many more women affected — nearly two dozen and possibly more — and that doctors may be missing some of the signs.

The new study in the journal JAMA Oncology found that approximately one in 7,000 women who get breast implants will develop a rare form of cancer called breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.

Read Full Article

3/21/17: FDA Updates Warning on Link Between Textured Breast Implants and Rare Cancer

On March 21, 2017, the U.S. Food and Drug Administration (FDA) updated its 2011 warning about a link between breast implants and a very rare form of cancer: anaplastic large-cell lymphoma. Because the cancer is linked to breast implants, the FDA calls the cancer breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).

According to the FDA, “All of the information to date suggests that women with breast implants have a very low but increased risk of developing anaplastic large-cell lymphoma compared to women who do not have breast implants.” The risk of BIA-ALCL is higher in women who have textured implants, which have a bumpy surface, as opposed to smooth implants, according to the FDA.

Read Full Article

GET YOUR FREE BREAST IMPLANT CASE REVIEW TODAY

Breast implant settlements are now being negotiated, but there is a limited window to pursue help. If you think you, a friend, or a family member may qualify, get your free case review today… before it’s too late!

  • * Submit now to learn if you may be eligible for a cash settlement or call (800) 511-3838 now.

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

LATEST ARTICLES

Why Post-Market Medical Device Follow-up is Necessary But Ignored or Hidden

As someone who’s had medical issues ranging from chronic pain to infertility, I’m no stranger to being poked, prodded, given a plethora of prescriptions, and feeling more like an alien abduction than a patient being presented solutions to feel better. Sound familiar?

Why Post-Market Medical Device Follow-up is Necessary But Ignored or Hidden

And why do we subjugate ourselves to being guinea pigs to test which therapies, pills, and mechanical parts will torment our bodies? It’s simple. We’re desperate for help and we trust the men and women in scrubs and suits to honestly want to help us. The FDA’s fast tracked 510(k) process,  doctors receiving “gifts” from pharmaceutical companies for prescribing their products, and sky high drug prices are just a few examples of the many parts of the system that are broken at the expense of patient health. Here’s another important flaw with the FDA and Big Pharma: their lack of post-market medical device follow-up.

But why should you take the time to learn about this? Consider these statistics:

  • In 2018, medtech (medical technology) stocks climbed 26%.
  • About 1.4 million hip and knee replacement surgeries were performed in 2017 alone and the number continues to increase each year.
  • The U.S. medical device market was $147.7 billion in 2016 and is projected to grow to $173 billion in 2019.

If you don’t already have a medical device, chances are high that you’ll either have one or you know someone who has one. Plus, this is big money for pharmaceutical companies so a variety of products are probably going to be advertised or recommended to you. Don’t you want to make sure that something this important is proven to help and not harm you?

The FDA’s 510(k) Approval and Post-Market Follow-up Process

The FDA established the 510(k) process to promote medical innovation and approve needed products to market quickly. However, this once “noble” function has now turned into a manipulation of Big Pharma to speed devices to market to for profit and to bypass expensive testing. The 510(k) process allows the FDA to fast-track paperwork through the system as pharmaceutical companies base their devices on previously approved ones… all without human clinical trials.

There are many problems to this practice. First of all, the products that they’re comparing the new one to may have been ineffective or harmful and taken off the market (such as the case involving Protegen transvaginal mesh). Secondly, this is how 70 percent of medical devices are being approved; again, WITHOUT human clinical trials. Is it any wonder why there are so many health complications and recalls concerning medical devices?!? Finally, the FDA is understaffed and underfunded which makes approving, monitoring, and following up on drugs and medical devices a nightmare.

Post market follow-up is critical to patient safety, as the FDA explains that the requirements, “include such things as tracking systems, reporting of device malfunctions, serious injuries or deaths, and registering the establishments where devices are produced or distributed. Postmarket requirements also include postmarket surveillance studies required under section 522 of the act as well as post-approval studies required at the time of approval of a premarket approval (PMA), humanitarian device exemption (HDE), or product development protocol (PDP) application.”

Let’s take a closer look at a recent example that hit the news in March 2019. Mentor Worldwide MemoryShape breast implants were approved in 2013. It came to the FDA’s attention that the company failed to enrol the required number of subjects in the post market study, had poor follow-up rates with patients (only 61 percent), and significant data wasn’t consistent.

These studies are particularly important because in 2016 it was determined that breast implants can cause breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, which is a type of non-Hodgkin’s lymphoma (cancer of the immune system). Post-market surveillance could not only ensure the safety of those in the study, but it can provide valuable information to prevent future patients from suffering from this disease.

Post-market surveillance is a critical part of the FDA’s job and public health depends on it. To quickly approve high risk medical devices and neglect monitoring how they work is not only negligent, but it deliberately disregards the health of the millions of patients that the FDA and pharmaceutical companies claim to be helping. It’s time to put patient health first.

 

##
Sources
“FDA warns J&J unit and Sientra over breast implant compliance”. Medical Device Network. Accessed March 25, 2019. https://www.medicaldevice-network.com/news/fda-warns-jj-sientra-breast-implants/
“Robots, DNA And Implantable Devices — Why 2019 Isn’t Your Dad’s Medtech”. Investor’s Business Daily. Accessed March 25, 2019. https://www.investors.com/news/technology/medical-equipment-medtech-2019-preview/
“Defenders: How medical devices are approved by the FDA and why some say it no longer works” KVUE. Accessed March 25, 2019. https://www.kvue.com/article/news/defenders-how-medical-devices-are-approved-by-the-fda-and-why-some-say-it-no-longer-works/269-2a9bfbe6-dd7d-4b2b-a0c1-6bebe24998cb
“Postmarket Requirements (Devices)”. FDA. Accessed April 2, 2019. https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/default.htm
“Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)”. FDA. Accessed April 2, 2019. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm

Why Are There So Many Drug and Medical Device Recalls?

As an advocacy group that strives to keep the FDA and big pharmaceutical companies accountable, we’ve seen our share of hundreds of thousands of people angry, disillusioned, and scared because their medicine or medical device has been recalled. They trusted that their doctor or surgeon chose the best decision for their condition. They put their faith in the company that produced their drug or implant to monitor their materials for safety. The believed that the FDA would only approve products that were properly tested and proven safe. Now many of these patients are living in a new normal where they’re worried about whether their pills are safe or they’re in excruciating pain from an implant that can’t be removed. How can this happen? Why does it seem that drugs and medical devices are being recalled more than ever before?

Why Are There So Many Drug and Medical Device Recalls?

Reasons for Recalls

Drug and medical device recalls can either be required by the FDA based on reports they’ve been receiving or it can be voluntary on behalf of the company when their product(s) are potentially unsafe. Here are the main reasons for recalling a medical product:

  • Health Risks – If a medicine or implant is found to harm patients and causes a high potential for injury, then it could be recalled. For example, phenylpropanolamine (PPA), a drug that was used in decongestants and weight loss medicines, was recalled because it was found to increase the risk of hemorrhagic stroke (bleeding in the brain).
  • Poor labeling or packaging – If the dosing instructions are confusing, if the dosing device is faulty, or perhaps the packaging proves not to be childproof, then it could be recalled.
  • Mislabeled – Let’s say that you purchased a generic medication that was labeled gluten free but it in fact did contain gluten, then the company would have to rectify this error.
  • Compromised Manufacturing – This has been in the news a lot lately. Recently (January 2019) it was found that the popular blood pressure medication Valsartan was contaminated with N-nitrosodimethylamine, or NDMA, a possibly cancer-causing substance and an additional contaminant called nitrosodiethylamine, or NDEA.  

2018 – The Year of the Recall

Let’s look at some of the stats for 2018 from R&D Magazine to see how they were broken down into the above categories:

Pharmaceuticals (percentage of total drug recalls)

  • Failure to meet product specifications: 25%
  • Deviations from current Good Manufacturing Practice (cGMP): 23.9%
  • Sterility: 12%
  • Mislabeling: 10.9%
  • Foreign Materials: 7.6%

Medical Devices (number of recalls per cause)

  • Software issue: 79
  • Mislabeling issue: 43
  • Quality issue: 36
  • Sterility issue: 27

A Few of the Top Drug and Medical Device Recalls of 2018:

Other Important Facts to Know

  • Five companies reported ten or more recalls in the quarter. This is the highest number since Q3 2016 and the second highest since Q3 2013.
  • You can check the FDA’s website to see if your medication or implant has been recalled by clicking here.

Why Are There So Many Drug and Medical Device Recalls?

There are many reasons why the number of recalls are increasing. First of all, we’ve talked a lot about how the FDA and pharmaceutical companies fast-track medical devices to market without testing using the 510(k) process. Another problem is that many products and drugs are produced overseas (learn more here).  A third broken part in the system is that Big Pharma funds not only the FDA, but politicians who monitor this appendage of the government. An additional glitch is that the FDA is overworked and underfunded; they can’t keep up with all the applications, adverse effect reports, and follow-up documents causing many issues to fall into the cracks.

Clearly the FDA is broken at the cost of innocent patients and their health. It’s time we voice our concerns, educate ourselves about our health, and hold the FDA and Big Pharma accountable for harming millions of people.

 

##
Sources
“Drug Recalls Increased, Medical Device Recalls Decreased in Q3”. R&D Magazine. Accessed April 2, 2019. https://www.rdmag.com/news/2018/11/drug-recalls-increased-medical-device-recalls-decreased-q3
“What Is a Drug Recall?”. WebMD. Accessed April 2, 2019. https://www.webmd.com/a-to-z-guides/what-is-a-drug-recall#1

IVC Filter Use is Declining; What Does This Mean for Patients?

There are many drugs and medical devices that start out innocent enough: they are designed to help patients address difficult medical conditions and the benefits outweigh the risks in these specific situations. However, a common problem has occurred in which products become overused, over-marketed, and either used off-label or not according to manufacturer’s directions. This is certainly the case for IVC filters. Not only were they overused, but many times they were left in patients causing added risks to patient health.

IVC Filter Use is Declining; What Does This Mean for Patients?

Fortunately, a study published in the American Journal of Roentgenology found that IVC filter sales have dropped drastically over the past decade. “Between 2009 and 2015, IVC filter utilization across the United States declined by 36.3% in the Medicare population and by 26.6% in the privately insured population,” explained a statement from the Harvey L. Neiman Health Policy Institute.

This decline in sales is a win for patients due to the overuse and risks that these devices pose. IVC filters are prongs that form a tent-like structure to trap blood clots in the inferior vena cava, a large vein that carries blood to the heart. If a blood clot enters the heart or lungs, irreparable damage could take place.

IVC filters were supposed to be used in patients who were diagnosed with blood conditions that would be harmed from use of anticoagulants. “Filters should be considered for patients who cannot be anticoagulated and for those who fail anticoagulation for proximal DVT [deep vein thrombosis] or PE [pulmonary embolism],” states Akhilesh Sista, MD, FSIR, section chief and associate professor at New York University Langone School of Medicine.

IVC filters should only be used in these extreme circumstances due to the added risk they bring to patients. IVC filter prongs may break and migrate causing tissue damage and can even lodge in the heart. It has also been found that even though these medical devices have been labeled “retrievable” – meaning they should be removed after 29 to 54 days in most cases – many doctors fail to take these devices out of their patients putting them in danger.

Clearly the decline of IVC filter sales is a win for patients. These new statistics mean that doctors are carefully analyzing patient health verses the danger of using this device. If you have one of these medical devices or have an upcoming surgery which may involve an IVC filter, be sure to discuss any questions you may have with your doctor to ensure that this is the best option for your health.

 

##
Sources
“The decline of state-level IVC filter utilization”. EurekAlert!. Accessed April 8, 2019. https://www.eurekalert.org/pub_releases/2019-04/hlnh-tdo040419.php
“IVC filter overuse declining, but retrieval rates remain low”. Healio. Accessed April 8, 2019. https://www.healio.com/cardiac-vascular-intervention/venous/news/online/%7Bc384ddb8-e89b-4c26-9ee4-f514e48567da%7D/ivc-filter-overuse-declining-but-retrieval-rates-remain-low

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

HON Code Certification

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

Protected by Copyscape

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

HON Code Certification

Pin It on Pinterest